While waiting for UnitedHealth Group’s (NYSE: UNH) purchase of it to finalize, Amedisys Inc. (Nasdaq: AMED) continues to grow its home health segment – primarily through non-Medicare revenue – and its higher-acuity care segment. The company reported its first-quarter earnings late Wednesday, which showed a 10% increase in total same store admissions in home health care and a 23% year-over-year jump in higher-acuity care admissions. Hospice admissions and revenue, meanwhile, dipped slightly year over year.
Read the full article: Amedisys Continues to Drive Growth in Home Health, High-Acuity Care Segments //
Source: https://homehealthcarenews.com/2024/04/amedisys-continues-to-drive-growth-in-home-health-high-acuity-care-segments/